Link Health Group LLC – Trademark Portfolio
Entity Type: 16
Link Health Group LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include P, POLARIX, and POLARIX.IO. The owner is based in Bridgewater, NJ.
783 Hardgrove Road
Bridgewater, NJ 08807
Showing of trademarks Trademarks
Trademark Classifications
Link Health Group LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Link Health Group LLC have?
Link Health Group LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Link Health Group LLC file in?
Link Health Group LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Link Health Group LLC's most well-known trademarks?
Link Health Group LLC's registered trademark portfolio includes well-known marks such as P, POLARIX, and POLARIX.IO. These are among 5 currently registered trademarks in the portfolio.
What is Link Health Group LLC's trademark registration success rate?
Link Health Group LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.